NNHF Unveiled at ASH2025: Expanding Beyond Haemophilia Care to Include SCD and Thalassemia
Amos Gitonga M, Associate Programme Manager-Southern Africa at Novo Nordisk Haemophilia and Haemoglobinopathies Foundation, shared a post on LinkedIn:
“While some of our Novo Nordisk Haemophilia and Haemoglobinopathies Foundation (NNHF) colleagues unveiled at ASH2025 in Orlando, we celebrated an inspiring Africa Unveil in Nairobi, Kenya NNHF Africa Unveil.
Together with partners from across Africa, we marked a bold new chapter: expanding beyond haemophilia care to include sickle cell disease (SCD) and thalassemia.
After two decades of impact, this is a new horizon and a momentum we are excited to carry forward. I look forward to working with incredible partners in Africa to strengthen care where it is most needed.
Our shared goal: to build an integrated model of care for haemophilia and SCD, while also advancing tailored approaches for each condition as needed. By leveraging shared resources, we aim to strengthen service delivery and improve access, and outcomes for people living with these conditions.”
Read more about ASH2025 on Hemostasis Today.
-
Jul 2, 2026, 11:52Praveen Kumar Tirlangi: A New Mechanism of Bleeding in Kyasanur Forest Disease
-
Jul 2, 2026, 11:17Heghine Khachatryan: Novel Biomarkers for Cancer-Associated Thrombosis
-
Jul 2, 2026, 11:17Neeraj Jain: Maharashtra Is Setting the Pace for Integrated Hemoglobinopathy Care
-
Jul 2, 2026, 11:11Safaa Hilal: Improving Postpartum Hemorrhage Outcomes Through Early Warning Scores
-
Jul 2, 2026, 11:10Maria Khan Junaidi: How Age Influences Intracerebral Hemorrhage Outcomes
-
Jul 2, 2026, 10:51Faces of Glanzmann Thrombasthenia – Glanzmann’s Research Foundation
-
Jul 2, 2026, 10:44Priya Sriskandarajah: Understanding Anemia of Chronic Disease in Clinical Practice
-
Jul 2, 2026, 10:42Flora Peyvandi: Germline-Targeting Vaccines for HIV
-
Jul 2, 2026, 10:29Nisar Ahmed: The Evolution of Anticoagulation Therapy